Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Day Hagan/Ned Davis Research Smart Sector ETF (Symbol: SSUS), we found that the implied analyst target price for the ETF based upon its underlying holdings is $57.97 per unit.
With SSUS trading at a recent price near $51.95 per unit, that means that analysts see 11.59% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of SSUS’s underlying holdings with notable upside to their analyst target prices are Microsoft Corporation (Symbol: MSFT), NVIDIA Corp (Symbol: NVDA), and Select Sector SPDR Trust – State Street Health Care Select Sector SPDR ETF (Symbol: XLV). Although MSFT has traded at a recent price of $407.78/share, the average analyst target is 39.30% higher at $568.03/share. Similarly, NVDA has 34.72% upside from the recent share price of $199.53 if the average analyst target price of $268.80/share is reached, and analysts on average are expecting XLV to reach a target price of $0.00/share, which is 15.82% above the recent price of $145.99. Below is a twelve month price history chart comparing the stock performance of MSFT, NVDA, and XLV:
Combined, MSFT, NVDA, and XLV represent 6.19% of the Day Hagan/Ned Davis Research Smart Sector ETF. Below is a summary table of the current analyst target prices discussed above:
| Name | Symbol | Recent Price | Avg. Analyst 12-Mo. Target | % Upside to Target |
|---|---|---|---|---|
| Day Hagan/Ned Davis Research Smart Sector ETF | SSUS | $51.95 | $57.97 | 11.59% |
| Microsoft Corporation | MSFT | $407.78 | $568.03 | 39.30% |
| NVIDIA Corp | NVDA | $199.53 | $268.80 | 34.72% |
| Select Sector SPDR Trust – State Street Health Care Select Sector SPDR ETF | XLV | $145.99 | $0.00 | 15.82% |
Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock’s trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research.
10 ETFs With Most Upside To Analyst Targets »
Also see:
Top Stocks Held By Bill Ackman
FI Options Chain
Dividend Calculator
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
